MétaCan
Menu
Back to cohort
Record W4405919577 · doi:10.1177/13524585241308134

Recommendations for essential medicines for multiple sclerosis in low-resource settings

2024· article· en· W4405919577 on OpenAlexaff
Deanna Saylor, Nick Rijke, Jennifer McDonell, Joanna Laurson-Doube, Jagannadha Avasarala, Elisa Baldin, Tapas Kumar Banerjee, Ivan Bogdanović, Riley Bove, DK Chawla, Kathleen Costello, Cinzia Del Giovane, Najoua El Abkari, Graziella Filippini, Matteo Foschi, Marien González‐Lorenzo, Anne Helme, Dina Jacobs, Tomáš Kalinčík, Aukje K. Mantel‐Teeuwisse, Silvia Minozzi, Cárlos Navas, Francesco Nonino, Oluwadamilola O. Ojo, B. Ozcan, Guy Peryer, Andrea Prato Chichiraldi, Ben Ridley, Dilraj Sokhi, Anthony Traboulsee, Irene Tramacere, Janis Siew Noi Tye, Simona Vecchi, Shanthi Viswanathan, Feng Xie, Maya Zeineddine, Holger J. Schünemann, Thomas Piggott

Bibliographic record

VenueMultiple Sclerosis Journal · 2024
Typearticle
Languageen
FieldMedicine
TopicMultiple Sclerosis Research Studies
Canadian institutionsMcMaster UniversityQueen's UniversityImpactUniversity of British ColumbiaMultiple Sclerosis Society of Canada
Fundersnot available
KeywordsFingolimodGlatiramer acetateOcrelizumabMultiple sclerosisMedicineTeriflunomideCladribineAlemtuzumabContext (archaeology)Interferon beta-1aPhysical therapyRituximabIntensive care medicineInternal medicineInterferon betaImmunologyLymphoma

Abstract

fetched live from OpenAlex

BACKGROUND: Multiple sclerosis (MS) is a demyelinating disease of the central nervous system that, when untreated, can lead to significant disability in young adults. Despite the increase in the number of disease-modifying therapies (DMTs), many people living with MS in low-resource settings do not have access to treatment. OBJECTIVE: The primary aim was to develop recommendations on the minimum essential DMTs for MS that should be available in low-resource settings. METHODS: The Multiple Sclerosis International Federation established an independent, international panel including healthcare professionals and people with MS. This panel, in collaboration with the Cochrane MS Group and McMaster GRADE Centre, reviewed evidence for use of MS DMTs following standardized GRADE protocols including consideration of balance of benefits and harms; certainty of evidence; resources required and cost-effectiveness and values, equity, feasibility and availability in low-resource settings. RESULTS: For active and/or worsening forms of relapsing MS, the panel recommends use of ocrelizumab, cladribine, fingolimod, dimethyl fumarate, interferon beta and glatiramer acetate. For active and/or worsening forms of progressive MS, the panel recommends use of rituximab, ocrelizumab, glatiramer acetate, fingolimod and interferon beta. CONCLUSIONS: Recommendations for the minimum essential DMTs for MS in low-resource settings were developed based on robust consideration of evidence and relevant context.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.007
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.249
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0030.007
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0000.001
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.121
GPT teacher head0.344
Teacher spread0.223 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueMultiple Sclerosis JournalSame topicMultiple Sclerosis Research StudiesFrench-language works237,207